Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma

CONTEXT: Serum creatinine has been reported to increase in patients receiving Vemurafenib, yet neither the prevalence nor the mechanism of this adverse event are known. OBJECTIVE: We aimed to evaluate the frequency and the mechanisms of increases in plasma creatinine level in patients receiving Vemu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurabielle, Charlotte, Pillebout, Evangéline, Stehlé, Thomas, Pagès, Cécile, Roux, Jennifer, Schneider, Pierre, Chevret, Sylvie, Chaffaut, Cendrine, Boutten, Anne, Mourah, Samia, Basset-Seguin, Nicole, Vidal-Petiot, Emmanuelle, Lebbé, Céleste, Flamant, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773169/
https://www.ncbi.nlm.nih.gov/pubmed/26930506
http://dx.doi.org/10.1371/journal.pone.0149873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773169/
https://www.ncbi.nlm.nih.gov/pubmed/26930506
http://dx.doi.org/10.1371/journal.pone.0149873

Ejemplares similares